Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Elevated circulating fatty acid concentration is a hallmark of insulin resistance and is at least in part attributed to the action of adipose tissue-derived tumor necrosis factor-alpha (TNF-alpha) on lipolysis. Cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (
CIDEA
) belongs to a family of proapoptotic proteins that has five known members in humans and mice. The action of
CIDEA
is unknown, but
CIDEA
-null mice are resistant to obesity and diabetes. We investigated
CIDEA
in adipose tissue of obese and lean humans and mice. The mRNA was expressed in white human fat cells and in brown mouse adipocytes. The adipose mRNA expression of
CIDEA
in mice was not influenced by obesity. However,
CIDEA
expression was decreased twofold in obese humans and normalized after weight reduction. Low adipose
CIDEA
expression was associated with several features of the metabolic syndrome. Human adipocyte depletion of
CIDEA
by RNA interference stimulated lipolysis and increased TNF-alpha secretion by a posttranscriptional effect. Conversely, TNF-alpha treatment decreased adipocyte
CIDEA
expression via the mitogen-activated protein kinase
c-Jun
NH(2)-terminal kinase. We propose an important and human-specific role for
CIDEA
in lipolysis regulation and metabolic complications of obesity, which is at least in part mediated by cross-talk between
CIDEA
and TNF-alpha.
...
PMID:A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity. 1591 94